Sun Pharma Announces Appointment of Richard Ascroft as CEO North America - PR Newswire
3 weeks ago • Google News
Sun Pharmaceutical Industries Limited (SUNPHARMA)
NSEINR 16720.57%
Price Chart
Key Statistics
Market Cap
INR 4.03T
P/E Ratio
36.63
Revenue (TTM)
INR 525.78B
Volume
1.3M
52W High
INR 1942.23
52W Low
INR 1540.67
Dividend Yield
0.66%
Beta
0.38
Technicals
50-Day MA
1693.844
200-Day MA
1751.7812
52 Week High
1942.2259
52 Week Low
1540.673
About SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and .
Employees
N/A
Headquarters
Mumbai, India
CEO
Mr. Dilip Shantilal Shanghvi
Latest News
Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs - ProPublica
4 weeks ago • Google News
India's Sun Pharma names Kirti Ganorkar as managing director - Reuters
5 weeks ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
39.89
Percentile: 86.78
Environmental Risk Score
3.07
Percentile: 4
Social Risk Score
25.2
Percentile: 4
Governance Risk Score
18.13
Percentile: 4
Controversy Level
ESG data provided by Sustainalytics, Inc.
SUNPHARMA
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg